{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:40:19Z","timestamp":1759365619825,"version":"build-2065373602"},"reference-count":25,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Pharmacy"],"abstract":"<jats:p>Drug\u2013radiopharmaceutical interactions can significantly alter radiotracer biodistribution, complicating diagnostic accuracy. This case report describes a 64-year-old male who underwent a Technetium-99m-methoxyisobutyl isonitrile (99mTc-MIBI) parathyroid scan for suspected primary hyperparathyroidism. Initially, the patient was asked to discontinue his medications for his chronic illnesses for 24 h prior to the scan. However, the images revealed significantly reduced counts\/tracer uptake in the thyroid, parathyroid and cardiac tissues in both the early and delayed phases. After a detailed review of his medication profile, it was postulated that there were potential interactions involving multiple P-glycoprotein (P-gp) substrates with specific emphasis on amlodipine, atorvastatin and telmisartan. The patient was advised to discontinue all medications for 72 h prior to the date of a repeat scan which was scheduled for two weeks after his initial scan. The repeat scan successfully detected a small focus of marked tracer retention in the left inferior parathyroid bed, suggestive of a small parathyroid adenoma. Post-surgery, the focus identified on the scan was removed and histologically confirmed to be a parathyroid adenoma. This is the first report of its kind among nuclear medicine patients in Jamaica. It highlights the importance of reviewing medication history prior to nuclear imaging, particularly when using radiotracers affected by P-gp mechanisms. This is crucial for mitigating against false-negative results, thus ensuring accurate diagnosis and appropriate clinical management.<\/jats:p>","DOI":"10.3390\/pharmacy13050140","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T07:58:13Z","timestamp":1759305493000},"page":"140","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Possible Drug\u2013Radiopharmaceutical Interaction in 99mTc-Sestamibi Parathyroid Imaging"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9788-4505","authenticated-orcid":false,"given":"Tracia-Gay","family":"Kennedy-Dixon","sequence":"first","affiliation":[{"name":"Faculty of Medical Sciences, University of the West Indies, Mona Campus, Kingston 7, Jamaica"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mellanie-Anne","family":"Didier","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Division, Department of Diagnostic & Interventional Radiology, University Hospital of the West Indies, Mona Campus, Kingston 7, Jamaica"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisha","family":"Allen-Dougan","sequence":"additional","affiliation":[{"name":"Faculty of Medical Sciences, University of the West Indies, Mona Campus, Kingston 7, Jamaica"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Glegg","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Division, Department of Diagnostic & Interventional Radiology, University Hospital of the West Indies, Mona Campus, Kingston 7, Jamaica"},{"name":"Office of the Principal, University of the West Indies, Mona Campus, Kingston 7, Jamaica"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4268-5960","authenticated-orcid":false,"given":"Maxine","family":"Gossell-Williams","sequence":"additional","affiliation":[{"name":"Faculty of Medical Sciences, University of the West Indies, Mona Campus, Kingston 7, Jamaica"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1590\/S0124-00642008000300013","article-title":"Radiopharmaceutical Drug Interactions","volume":"10","year":"2008","journal-title":"Rev. Salud Publica"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/BF00947972","article-title":"Drug interactions with radiopharmaceuticals","volume":"21","author":"Hesslewood","year":"1994","journal-title":"Eur. J. Nucl. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.18773\/austprescr.2014.050","article-title":"P-glycoprotein and its role in drug-drug interactions","volume":"37","author":"Finch","year":"2014","journal-title":"Aust. Prescr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","article-title":"DrugBank 6.0: The DrugBank Knowledgebase for 2024","volume":"52","author":"Knox","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1054\/bjoc.2000.1621","article-title":"Comparison of 99mTc-sestamibi and doxorubicin to monitor inhibition of P-glycoprotein function","volume":"84","author":"Muzzammil","year":"2001","journal-title":"Br. J. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2165\/00002018-199308040-00003","article-title":"Adverse Reactions and Drug Interactions with Radiopharmaceuticals","volume":"8","author":"Sampson","year":"1993","journal-title":"Drug Saf."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1124\/pr.113.007518","article-title":"Transporters and Drug-Drug Interactions: Important Determinants of Drug Disposition and Effects","volume":"65","author":"Konig","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"ref_8","unstructured":"(2025, April 26). Available online: https:\/\/www.drugs.com\/drug_information.html."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3329\/bjnm.v17i2.28201","article-title":"Sestamibi Positive vs. Negative Scan in Primary Hyperparathyroidism; A Clinical Dilemma","volume":"17","author":"Rahman","year":"2014","journal-title":"Bangladesh J. Nuclear Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4103\/1450-1147.203073","article-title":"Ultrastructure of Hyperfunctioning Parathyroid Glands: Does it explain Various Patterns of 99mTc-sestamibi Uptake","volume":"16","author":"Elgazzar","year":"2017","journal-title":"World J. Nucl. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0969-8051(01)00259-1","article-title":"Correlation between P-glycoprotein (P-gp) expression in parathyroid and Tc-99m MIBI parathyroid image findings","volume":"28","author":"Sun","year":"2001","journal-title":"Nucl. Med. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"816","DOI":"10.2169\/internalmedicine.43.816","article-title":"A Patient with Classic Severe Primary Hyperparathyroidism in Whom both Tc-99m MIBI Scintigraphy and FDG_PET Failed to Detect the Parathyroid Tumor","volume":"43","author":"Seki","year":"2004","journal-title":"Intern. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.4067\/s0034-98872017000801021","article-title":"False Negative SPECT Parathyroid Scintigraphy with Sestamibi in Patients with Primary Hyperparathyroidism","volume":"145","author":"Paillahueque","year":"2017","journal-title":"Rev. Med. Chile"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.amjsurg.2005.07.007","article-title":"Hyperparathyroidism but a negative sestamibi scan: A clinical dilemma","volume":"190","author":"Slitt","year":"2005","journal-title":"Am. J. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e240265","DOI":"10.1530\/EC-24-0265","article-title":"False-negative 99mTc-sestamibi scans: Factors and outcomes in primary hyperparathyroidism","volume":"13","author":"Alemadi","year":"2024","journal-title":"Endocr. Connect."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00268-008-9841-0","article-title":"Sestamibi SPECT Intensity Scoring System in Sporadic Primary Hyperparathyroidism","volume":"33","author":"Yip","year":"2009","journal-title":"World J. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00268-001-0177-2","article-title":"Relation between Technetium 99m-methoxyisobutylisonitrile Accumulation and Multidrug Resistance Protein in the Parathyroid Glands","volume":"26","author":"Yamaguchi","year":"2001","journal-title":"World J. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.surg.2004.06.047","article-title":"Effect of Calcium Channel Blockers on the sensitivity of preoperative 99mTc-MIBI SPECT for hyperparathyroidism","volume":"136","author":"Freidman","year":"2004","journal-title":"Surgery"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1211\/0022357043941","article-title":"Concentration dependency of modulatory effect of amlodipine on P-glycoprotein efflux activity of doxorubicin\u2014A comparison with tamoxifen","volume":"56","author":"Darvari","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1470320319862741","DOI":"10.1177\/1470320319862741","article-title":"Effects of telmisartan and losartan treatments on bone turnover markers in patients with newly diagnosed stage I hypertension","volume":"20","author":"Erarslan","year":"2019","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1210\/jc.2014-3949","article-title":"Aldosterone, Parathyroid Hormone, and the Use of Renin-Angiotensin-Aldosterone System Inhibitors: The Multi-Ethnic Study of Atherosclerosis","volume":"100","author":"Brown","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1210\/jc.2018-01185","article-title":"Statin Treatment Decreases Mitochondrial Respiration But Muscle Coenzyme Q10 Levels Are Unaltered: The LIFESTAT Study","volume":"104","author":"Dohlmann","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jcsm.12654","article-title":"Effects of statins on mitochondrial pathways","volume":"12","author":"Mollazadeh","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s13139-021-00722-6","article-title":"Usefulness of 99mTc SESTAMIBI Scintigraphy in Persistent Hyperparathyroidism after Kidney Transplant","volume":"55","author":"Shin","year":"2021","journal-title":"Nucl. Med. Mol. Imaging"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1245\/s10434-012-2325-3","article-title":"Primary Hyperparathyroidism and Negative Tc99 Sestamibi Imaging: To Operate or Not?","volume":"19","author":"Dy","year":"2012","journal-title":"Ann. Surg. Oncol."}],"container-title":["Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2226-4787\/13\/5\/140\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T08:42:55Z","timestamp":1759308175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2226-4787\/13\/5\/140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["pharmacy13050140"],"URL":"https:\/\/doi.org\/10.3390\/pharmacy13050140","relation":{},"ISSN":["2226-4787"],"issn-type":[{"value":"2226-4787","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]}}}